JPH09509581A - 酵母株および修飾アルブミン - Google Patents
酵母株および修飾アルブミンInfo
- Publication number
- JPH09509581A JPH09509581A JP7522762A JP52276295A JPH09509581A JP H09509581 A JPH09509581 A JP H09509581A JP 7522762 A JP7522762 A JP 7522762A JP 52276295 A JP52276295 A JP 52276295A JP H09509581 A JPH09509581 A JP H09509581A
- Authority
- JP
- Japan
- Prior art keywords
- albumin
- yeast
- modified
- arg
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
- C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. アルブミンが培地中に分泌されるように培地で酵母を培養することを含 む、アルブミンを産生および分泌するように遺伝子修飾された酵母からの分泌に よりアルブミンを製造するための方法であって、該酵母細胞が減少したレベルの 酵母アスパルチルプロテアーゼ3タンパク質分解活性を有することを特徴とする 方法。 2. タンパク質分解活性が、ポリペプチドにおける一塩基性部位におよび一 対の塩基性アミノ酸に特異的なエンドプロテアーゼ活性である、請求項1に記載 の方法。 3. 酵母がS.cerevisiaeである、請求項1または2に記載の方法。 4. 酵母が機能性YAP3遺伝子またはそのホモローグを欠く、請求項1、 2または3に記載の方法。 5. 酵母細胞が減少したレベルのS.cerevisiae Kex2pタンパク質分解 活性を更に有する、請求項1〜4のいずれか一項に記載の方法。 6. アルブミンがヒトアルブミンである、請求項1〜5のいずれか一項に記 載の方法。 7. アルブミンをコードするポリヌクレオチド配列と、第一ポリヌクレオチ ド配列から発現されたアルブミンを酵母から分泌させる分泌シグナルをコードす る第二ポリヌクレオチド配列とを含んだ酵母細胞の培養物であって、該酵母細胞 が減少したレベルの酵母アスパルチルプロテアーゼ3タンパク質分解活性を有す ることを特徴とする培養物。 8. アルブミンがヒトアルブミンである、請求項7に記載の培養物。 9. 酵母がS.cerevisiaeである、請求項7または8に記載の培養物。 10. シグナルが、酵母からアルブミンの放出前に、酵母により開裂される 、 請求項7〜9のいずれか一項に記載の培養物。 11. 酵母細胞が減少したレベルのKex2pタンパク質分解活性を更に有 する、請求項7〜10のいずれか一項に記載の培養物。 12. 分泌シグナルがKex2p以外のプロテアーゼによりアルブミンから 開裂される、請求項11に記載の培養物。 13. 天然アルブミンと少くとも90%の配列同一性を有する修飾アルブミ ンであって、該天然アルブミンは酵母で発現および分泌されたときに酵母アスパ ルチルプロテアーゼ3(Yap3p)による開裂をうけやすく、このような開裂 を受けにくいことを特徴とする修飾アルブミン。 14. 天然アルブミンタンパク質に存在する一塩基性アミノ酸を欠く、請求 項13に記載の修飾アルブミン。 15. 一塩基性アミノ酸がアルギニンである、請求項13または14に記載 の修飾アルブミン。 16. 天然アルブミンに存在する一対の塩基性アミノ酸を更に欠く、請求項 14または15に記載の修飾アルブミン。 17. 一対のアミノ酸がLys、Lys;Lys、Arg;Arg、Lys ;またはArg、Argである、請求項16に記載の修飾アルブミン。 18. 天然アルブミンがヒトアルブミンであり、修飾タンパク質がArg41 0 を欠き、場合により残基413および414が各々リジンまたはアルギニンで はない、請求項13に記載の修飾アルブミン。 19. アミノ酸置換R410A、K413Q、K414Qを有するヒトアル ブミンである、請求項18に記載の修飾アルブミン。 20. 請求項13〜19のいずれか一項に記載の修飾アルブミンをコードす るポリヌクレオチド。 21. 請求項20に記載されたポリヌクレオチドと、修飾アルブミンが酵母 で発現されるような転写シグナルと、そして修飾アルブミンが酵母から分泌され るように上記ポリヌクレオチドと隣接する更なるポリヌクレオチドとを含む酵母 。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9404270.2 | 1994-03-05 | ||
GB9404270A GB9404270D0 (en) | 1994-03-05 | 1994-03-05 | Yeast strains and modified albumins |
PCT/GB1995/000434 WO1995023857A1 (en) | 1994-03-05 | 1995-03-01 | Yeast strains and modified albumins |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09509581A true JPH09509581A (ja) | 1997-09-30 |
JP3795073B2 JP3795073B2 (ja) | 2006-07-12 |
Family
ID=10751353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52276295A Expired - Lifetime JP3795073B2 (ja) | 1994-03-05 | 1995-03-01 | 酵母株および修飾アルブミン |
Country Status (13)
Country | Link |
---|---|
US (1) | US5965386A (ja) |
EP (1) | EP0749478B1 (ja) |
JP (1) | JP3795073B2 (ja) |
KR (1) | KR100372514B1 (ja) |
AT (1) | ATE260338T1 (ja) |
AU (1) | AU683728B2 (ja) |
CA (1) | CA2183241C (ja) |
DE (1) | DE69532603T2 (ja) |
DK (1) | DK0749478T3 (ja) |
ES (1) | ES2216007T3 (ja) |
GB (2) | GB9404270D0 (ja) |
PT (1) | PT749478E (ja) |
WO (1) | WO1995023857A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014510518A (ja) * | 2011-02-15 | 2014-05-01 | メディミューン,エルエルシー | Hsa関連組成物および使用方法 |
JP5883780B2 (ja) * | 2010-03-26 | 2016-03-15 | アサヒグループホールディングス株式会社 | 酵母の培養方法 |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
WO1998001473A1 (en) * | 1996-07-05 | 1998-01-15 | Novo Nordisk A/S | Method for the production of precursors of insulin, precursors of insulin analogues, and insulin like peptides |
WO1998001535A1 (en) * | 1996-07-05 | 1998-01-15 | Novo Nordisk A/S | Method for the production of polypeptides |
US6110703A (en) * | 1996-07-05 | 2000-08-29 | Novo Nordisk A/S | Method for the production of polypeptides |
US6274305B1 (en) | 1996-12-19 | 2001-08-14 | Tufts University | Inhibiting proliferation of cancer cells |
US6265186B1 (en) | 1997-04-11 | 2001-07-24 | Dsm N.V. | Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces |
AU2241699A (en) * | 1998-01-27 | 1999-08-09 | Board Of Regents Of The University And Community College System Of Nevada, The | Expression of proteolytically-sensitive peptides |
GB9902000D0 (en) | 1999-01-30 | 1999-03-17 | Delta Biotechnology Ltd | Process |
EP2267026A1 (en) * | 2000-04-12 | 2010-12-29 | Human Genome Sciences, Inc. | Albumin fusion proteins |
DE60140461D1 (de) * | 2000-09-11 | 2009-12-24 | Genzyme Corp | Muc1 extrazelluläre domäne und zusammensetzungen für krebsbehandlung, und davon abgeleitete verfahren |
EP1958642A1 (en) * | 2000-12-22 | 2008-08-20 | Dana-Farber Cancer Institute | Regulation of cell growth by MUC1 |
US20050054051A1 (en) * | 2001-04-12 | 2005-03-10 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US7507413B2 (en) * | 2001-04-12 | 2009-03-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
JP2003047471A (ja) * | 2001-08-01 | 2003-02-18 | Kirin Brewery Co Ltd | 異種タンパク質の分泌生産に優れた改変酵母およびその酵母を用いた異種タンパク質の製造法 |
US7176278B2 (en) | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
AU2002364587A1 (en) | 2001-12-21 | 2003-07-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
PT1463751E (pt) | 2001-12-21 | 2013-08-26 | Human Genome Sciences Inc | Proteínas de fusão de albumina |
US20080194481A1 (en) | 2001-12-21 | 2008-08-14 | Human Genome Sciences, Inc. | Albumin Fusion Proteins |
WO2003066078A1 (en) | 2002-02-07 | 2003-08-14 | Delta Biotechnology Limited | Hiv inhibiting proteins |
US7879365B2 (en) * | 2002-02-07 | 2011-02-01 | The Trustees Of Columbia University In The City Of New York | Zinc salt compositions for the prevention of dermal and mucosal irritation |
WO2003091431A1 (fr) | 2002-04-26 | 2003-11-06 | Kirin Beer Kabushiki Kaisha | Methylotrophe produisant une chaine de sucre de type mammifere |
KR100496758B1 (ko) * | 2002-06-29 | 2005-06-22 | 한국생명공학연구원 | 한세눌라 폴리모르파 앱신 유전자 결손 변이주 및 이를이용한 재조합 단백질 생산 방법 |
WO2004092339A2 (en) * | 2003-04-11 | 2004-10-28 | Ilex Products, Inc. | Modulation of muc1 mediated signal transduction |
US8129506B2 (en) * | 2003-10-24 | 2012-03-06 | Genzyme Corporation | Modulation of the interaction of MUC1 with MUC1 ligands |
GB0329681D0 (en) | 2003-12-23 | 2004-01-28 | Delta Biotechnology Ltd | Gene expression technique |
GB0329722D0 (en) | 2003-12-23 | 2004-01-28 | Delta Biotechnology Ltd | Modified plasmid and use thereof |
RU2006128593A (ru) * | 2004-01-07 | 2008-02-20 | Тримерис, Инк. (Us) | Синтетические пептиды, производные области hr2 белка gp41 вич, и их применение в терапии для ингибирования проникновения вируса иммунодефицита человека |
EP1718367A1 (en) * | 2004-02-23 | 2006-11-08 | Genzyme Corporation | Muc1 antagonist enhancement of death receptor ligand-induced apoptosis |
EP2301963A1 (en) | 2004-09-23 | 2011-03-30 | Vasgene Therapeutics, Inc. | Polypeptide compounds for inhibiting angiogenesis and tumor growth |
DK2330200T3 (en) | 2004-12-23 | 2017-07-24 | Albumedix As | GENE EXPRESSION TECHNIQUE |
AU2006344395B2 (en) | 2005-10-13 | 2013-05-02 | Human Genome Sciences, Inc. | Methods and compositions for use in treatment of patients with autoantibody positive diseases |
AR059300A1 (es) * | 2006-02-02 | 2008-03-26 | Trimeris Inc | Peptidos inhibidores de la fusion de vih con propiedades biologicas mejoradas |
ATE524493T1 (de) | 2006-07-24 | 2011-09-15 | Biorexis Pharmaceutical Corp | Exendin-fusionsproteine |
JP5256199B2 (ja) | 2006-08-07 | 2013-08-07 | テヴァ バイオファーマシューティカルズ ユーエスエー,インコーポレーティッド | アルブミン−インスリン融合タンパク質 |
DK2615108T3 (en) | 2006-09-08 | 2017-01-30 | Ambrx Inc | Modified human plasma polypeptide or fc scaffolds and their applications |
US7972870B2 (en) | 2007-02-02 | 2011-07-05 | Dana-Farber Cancer Institute, Inc. | Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3 |
WO2008097844A2 (en) * | 2007-02-02 | 2008-08-14 | Dana -Farber Cancer Institute, Inc. | Methods and compositions relating to the regulation of apoptosis by muc1 and bh3- containing proapoptotic proteins |
MX2009010689A (es) * | 2007-04-03 | 2009-12-14 | Trimeris Inc | Formulaciones novedosas para el suministro de agentes terapeuticos de peptidos antivirales. |
WO2009019314A1 (en) | 2007-08-08 | 2009-02-12 | Novozymes A/S | Transferrin variants and conjugates |
BRPI0817697A2 (pt) * | 2007-09-25 | 2015-04-07 | Trimeris Inc | Método de síntese de um peptídeo, conjunto de fragmentos de peptídeo, e, peptídeo |
EP2393834B1 (en) | 2009-02-06 | 2013-04-17 | Novozymes Biopharma DK A/S | Purification process |
US9493545B2 (en) | 2009-02-11 | 2016-11-15 | Albumedix A/S | Albumin variants and conjugates |
EP3421491A3 (en) * | 2009-10-30 | 2019-03-27 | Albumedix Ltd | Albumin variants |
US8815541B2 (en) | 2009-11-25 | 2014-08-26 | Novo Nordisk A/S | Method for making polypeptides |
JP2013519392A (ja) | 2010-02-16 | 2013-05-30 | メディミューン,エルエルシー | Hsa関連組成物および使用方法 |
JP5969458B2 (ja) | 2010-04-09 | 2016-08-17 | アルブミディクス アクティーゼルスカブ | アルブミン誘導体及び変異体 |
US9045564B2 (en) | 2011-02-15 | 2015-06-02 | Medimmune, Llc | HSA-related compositions and methods of use |
CN103732628B (zh) | 2011-03-03 | 2017-06-23 | 酵活有限公司 | 多价杂多聚体骨架设计和构建体 |
US8822417B2 (en) | 2011-05-05 | 2014-09-02 | Novozymes Biopharma DIC A/S | Albumin variants |
EP2780364A2 (en) | 2011-11-18 | 2014-09-24 | Eleven Biotherapeutics, Inc. | Proteins with improved half-life and other properties |
BR112014018679A2 (pt) | 2012-03-16 | 2017-07-04 | Novozymes Biopharma Dk As | variantes de albumina |
JP6498601B2 (ja) | 2012-07-13 | 2019-04-10 | ザイムワークス,インコーポレイテッド | 多価ヘテロ多量体足場設計および構築物 |
BR112015010318A2 (pt) | 2012-11-08 | 2017-08-22 | Albumedix As | Variantes de albumina |
AU2014225678B2 (en) | 2013-03-06 | 2016-11-17 | Glaxosmithkline Llc | Host cells and methods of use |
WO2014165093A2 (en) | 2013-03-13 | 2014-10-09 | Bristol-Myers Squibb Company | Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto |
EP3027752B1 (en) * | 2013-07-01 | 2018-08-08 | Biocon Limited | Signal sequence for protein expression in pichia pastoris |
CN108137674B (zh) | 2015-08-20 | 2022-12-06 | 阿尔布梅迪克斯医疗有限公司 | 白蛋白变体和缀合物 |
BR112021008200A2 (pt) | 2018-10-29 | 2021-12-14 | Spin Therapeutics Llc | Composições e métodos para distúrbios de alfa-1-antitripsina |
US11739166B2 (en) | 2020-07-02 | 2023-08-29 | Davol Inc. | Reactive polysaccharide-based hemostatic agent |
CN114957448B (zh) * | 2022-06-08 | 2023-08-25 | 中国农业科学院生物技术研究所 | 一种高效表达α-乳白蛋白的酵母菌株和α-乳白蛋白及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01240191A (ja) * | 1988-02-16 | 1989-09-25 | Green Cross Corp:The | 酵母で機能する新規シグナルペプチドおよびこれを用いた異種蛋白質の分泌発現 |
EP0548012B1 (en) * | 1991-12-16 | 1997-09-03 | Novartis AG | Endoplastic reticulum-located recombinant dibasic endoprotease and uses thereof |
US5440018A (en) * | 1992-05-20 | 1995-08-08 | The Green Cross Corporation | Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
-
1994
- 1994-03-05 GB GB9404270A patent/GB9404270D0/en active Pending
-
1995
- 1995-03-01 JP JP52276295A patent/JP3795073B2/ja not_active Expired - Lifetime
- 1995-03-01 GB GB9616724A patent/GB2301365B/en not_active Revoked
- 1995-03-01 PT PT95909880T patent/PT749478E/pt unknown
- 1995-03-01 ES ES95909880T patent/ES2216007T3/es not_active Expired - Lifetime
- 1995-03-01 CA CA002183241A patent/CA2183241C/en not_active Expired - Lifetime
- 1995-03-01 AU AU18183/95A patent/AU683728B2/en not_active Expired
- 1995-03-01 DK DK95909880T patent/DK0749478T3/da active
- 1995-03-01 US US08/702,572 patent/US5965386A/en not_active Expired - Lifetime
- 1995-03-01 DE DE69532603T patent/DE69532603T2/de not_active Expired - Lifetime
- 1995-03-01 AT AT95909880T patent/ATE260338T1/de active
- 1995-03-01 WO PCT/GB1995/000434 patent/WO1995023857A1/en active IP Right Grant
- 1995-03-01 KR KR1019960704819A patent/KR100372514B1/ko not_active IP Right Cessation
- 1995-03-01 EP EP95909880A patent/EP0749478B1/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5883780B2 (ja) * | 2010-03-26 | 2016-03-15 | アサヒグループホールディングス株式会社 | 酵母の培養方法 |
JP2014510518A (ja) * | 2011-02-15 | 2014-05-01 | メディミューン,エルエルシー | Hsa関連組成物および使用方法 |
Also Published As
Publication number | Publication date |
---|---|
CA2183241A1 (en) | 1995-09-08 |
EP0749478A1 (en) | 1996-12-27 |
US5965386A (en) | 1999-10-12 |
GB2301365B (en) | 1997-07-30 |
GB2301365A (en) | 1996-12-04 |
EP0749478B1 (en) | 2004-02-25 |
CA2183241C (en) | 2002-05-21 |
GB9404270D0 (en) | 1994-04-20 |
AU1818395A (en) | 1995-09-18 |
ATE260338T1 (de) | 2004-03-15 |
GB9616724D0 (en) | 1996-09-25 |
DE69532603T2 (de) | 2005-01-05 |
DK0749478T3 (da) | 2004-06-28 |
JP3795073B2 (ja) | 2006-07-12 |
DE69532603D1 (de) | 2004-04-01 |
ES2216007T3 (es) | 2004-10-16 |
WO1995023857A1 (en) | 1995-09-08 |
KR100372514B1 (ko) | 2004-04-30 |
PT749478E (pt) | 2004-07-30 |
AU683728B2 (en) | 1997-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH09509581A (ja) | 酵母株および修飾アルブミン | |
KR100380532B1 (ko) | 효모균주 | |
CA1340772C (en) | Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences | |
EP0394538B1 (en) | A yeast cell of the genus schwanniomyces | |
US5759802A (en) | Production of human serum alubumin A | |
CA1326217C (en) | Method for preparing foreign protein in yeast, recombinant dna, transformant | |
JPH03500370A (ja) | ペプチドおよびdna配列 | |
JPH08512202A (ja) | Yap3シグナルペプチドをコードするdna構築体 | |
PL154427B1 (en) | Method for manufacturing and separating heterological protein through yarrow lipolytica culturing | |
US5667986A (en) | Yeast promoter for expressing heterologous polypeptides | |
US5218093A (en) | EGF variants and pharmaceutical use thereof | |
KR100490190B1 (ko) | 개량된 단백질 발현균주 | |
JP3359341B2 (ja) | 酵母プロモーター | |
US5585257A (en) | Process for the production of human lysozyme | |
EP0208706A1 (en) | Dna sequence useful for the production and secretion from yeast of peptides and proteins | |
JP3140488B2 (ja) | 融合タンパク質の試験管内プロセシング | |
JP3794760B2 (ja) | フィターゼ生産酵母 | |
WO1986000637A1 (en) | Yeast cloning vehicle | |
JPH0249715B2 (ja) | ||
JPH0322983A (ja) | MFα1リーダー配列を用いる酵母宿主によるヒト血清アルブミンAの製造 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040727 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20041025 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20041206 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050106 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050301 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050601 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050715 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050901 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20051018 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060112 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20060209 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060314 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060412 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090421 Year of fee payment: 3 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090421 Year of fee payment: 3 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090421 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100421 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110421 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110421 Year of fee payment: 5 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110421 Year of fee payment: 5 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120421 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120421 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130421 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130421 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140421 Year of fee payment: 8 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |